ListedMainboardEMCURE
Emcure Pharmaceuticals IPO
Emcure Pharmaceuticals IPO is a mainboard IPO raising ₹1,952 Cr at ₹960 – ₹1,008 a share. It listed on 10 Jul 2024 and trades at ₹1,866 today, +85.1% against its issue price of ₹1,008. It was subscribed 68× in total.
₹1,008
Issue price
₹1,866
Price now
+85.1%
Since issue price
10 Jul 2024
Listed on
68×Subscribed (final) · all exchanges
67.9 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Lead managers, and how their past issues have done
Median return since issue price across every IPO we hold this bank on. Not a forecast for this issue — a record.
| Lead manager | IPOs we hold them on | Of which we can price | Median return since issue |
|---|---|---|---|
| Axis Capital Limited | 123 | 114 | +18.1% |
| Kotak Mahindra Capital Company Limited | 85 | 79 | +26.0% |
| Jefferies India Private Limited | 32 | 29 | +12.8% |
| J. P. Morgan India Private Limited | 31 | 29 | +32.1% |
A bank appears on an issue we can price only when the company is matched to our price history, so the two counts differ. See the full league table →
Registrar
Contact them about allotment, refunds or unblocking your application amount — not the company, and not the exchange.
NameLink Intime India Private Limited
ContactShanti Gopalkrishnan
Emailemcure.ipo@linkintime.co.in
Phone+ 91 810 811 4949